Effects of a new 5α reductase inhibitor (Epristeride) on human prostate cell cultures

Prostate

Volumn 32, Issue 4, 1997, Pages 259-265

  Robinson, Emma J ^a   Collins, Anne T ^a   Robson, Craig N ^a   Neal, David E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Proliferation; Prostate specific antigen; TGF 1

Indexed keywords

ANDROGEN; ANDROSTANOLONE; DNA; EPRISTERIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ADULT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STROMA CELL;

ADULT; ANDROSTADIENES; CELL DIVISION; CELLS, CULTURED; DIHYDROTESTOSTERONE; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RNA, MESSENGER; TESTOSTERONE; TESTOSTERONE 5-ALPHA-REDUCTASE; THYMIDINE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030868961     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970901)32:4<259::AID-PROS5>3.0.CO;2-E     Document Type: Article

References (23)

1. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E: Male pseudohermaphroditism secondary to 5α reductase deficiency - A model for the role of androgens in both the development of the male phenotype and the evolution of male gender identity. J Steroid Biochem 1979;11:637-648.
2. Coffey DS, Pienta KJ: New concepts in studying the control of normal and cancer growth of the prostate. In: "Current Concepts and Approaches to the Study of Prostate Cancer," New York: Wiley-Liss, 1987:1-73.
3. Stoner E: Finasteride Study Group: The clinical effects of 5α reductase inhibitor, finasteride, on benign prostatic hyperplasia. J Urol 1992;147:1298-1302.
4. Issacs JT: Antagonistic effect of androgens on prostatic cell death. Prostate 1984;5:545-557.
5. Imperato-McGinley J, Shackleton C, Orlic S, Stoner E: C19 and C21 5β/5α metabolite ratios in subjects treated with the 5α reductase inhibitor finasteride: Comparison of male pseudohermaphrodites with inherited 5α reductase deficiency. J Clin Endocrinol Metab 1990;70:777-782.
6. Levy M, Brandt M, Sheedy KM, Dinh JT, Holt DA, Garrison LM, Bergsma DJ, Metcalf BW: Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α reductase isoform 2. J Steroid Biochem Mol Biol 1994;48:197-206.
7. Hsu S-M, Raine L: Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 1981;29:1349-1353.
8. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
9. Cussenot O, Berthon P, Cochand-Priollet B, Maitland NJ, Le Due A: Immunocytochemical comparison of cultured normal epithelial prostatic cells to prostatic tissue sections. Exp Cell Res 1994; 214:83-92.
10. Wada T, Yasutomi M, Hashmura K, Kunikata M, Tanaka T, Mori M: Vimentin expression in benign and malignant lesions in the human mammary gland. Anticancer Res 1992;12:1973-1982.
11. Collins AT, Zhiming B, Gilmore K, Neal DE: Androgen and estrogen responsiveness of stromal cells derived from human hyperplastic prostate: Estrogen regulation of the androgen receptor. J Endocrinol 1994;143:269-277.
12. Levine AC, Ren M, Huber GK, Krischenbaum A: The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 1992;130:2413-2419.
13. Darbre PD, King RJB: Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors. Cell 1987;51:521-528.
14. Diamond DA, Barrack ER: The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines. J Urol 1984;132:821-827.
15. Chung LWK, Gleave ME, Hsieh J, Hong S, Zhau HE: Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness. Cancer Surv 1991;11:91-121.
16. Cunha GR: Androgenic effects upon prostatic epithelium are mediated via trophic influences from stroma. In Kimball FA, Buhl AE, Carter DB (eds): "New Approaches to the Study of Benign Prostatic Hyperplasia," New York: Alan R. Liss, 1984: 81-102.
17. Peehl DM, Stamey TA: Serum free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Biol 1986;22:82-90.
18. McKeehen WL, Adams PS, Rosser MP: Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum free, primary cell culture. Cancer Res 1984;44:1998-2010.
19. Montgomery BT, Young CY-F, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ: Hormonal regulation of prostate specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP. Prostate 1992;21:63-73.
20. Story MT: Positive and negative modulators of prostate cell proliferation. Biomed Pharmacother [Suppl] 1994;48:35-41.
21. Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK: Influence of transforming growth factor-β1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 1993;22:183-197.
22. Kyprianou N, Issacs JT: Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 1988;123: 2124-2131.
23. Kyprianou N, English HE, Isaacs JT: Programmed cell death during regression of the PC-82 human prostate cancer following androgen ablation. Cancer Res 1990;59:3748-3753.